Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Epoetin beta + LFM-A13 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Epoetin beta | NeoRecormon|erythropoietin beta | |||
LFM-A13 | BTK inhibitor 36 JAK2 Inhibitor 17 | LFM-A13 inhibits BTK, with additional activity against JAK2 and PLK, potentially resulting in increased tumor cell apoptosis (PMID: 17098432, PMID: 15196000, PMID: 10092645, PMID: 30571407). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|